PHILADELPHIA, Pa.--(BUSINESS WIRE)—Context Therapeutics, a clinical-stage biopharmaceutical company focused on hormonally-driven cancers, announced that CEO Martin Lehr is a semifinalist for Ernst, & Young’s (EY) 2018 Entrepreneur of the Year for the Philadelphia region.

PHILADELPHIA, PA--Context Therapeutics, a clinical stage biopharmaceutical company announced that it has acquired worldwide rights to Apristor.